Jerusalem Pharmaceuticals Co. Ltd. (PLSE: JPH)
Health Care · Pharmaceuticals · PS
$3.60
+0.84% today · +73.1% 1Y
Jerusalem Pharmaceuticals Co. Ltd. (PLSE: JPH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $129.60M.
Over the last twelve months the share price has gained 73.1%, trading between 1.90 and 4.00.
Tweenvest scores Jerusalem Pharmaceuticals Co. Ltd. across four factors: quality 79/100, value 49/100, growth 57/100, dividend 78/100. Its strongest factor is quality.
JPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $129.60M
- Revenue (TTM)
- $51.36M
- P/E
- 13.15
- EPS
- 0.27
- Dividend yield
- 2.08%
- Beta (5Y)
- 0.43
- 52-week high
- $4.00
- 52-week low
- $1.90
- Avg volume (3M)
- —
- Shares outstanding
- 36.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.46 | -0.04% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $272.89 | -0.05% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $155.63 | +3.30% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.40 | +1.54% |
Figures last refreshed Aug 18, 2026.